Cancer patients over-represented in long COVID group

close up photo of a man wearing face mask

Cancer patients account for an outsized proportion of people who end up with persistent, troublesome symptoms after recovering from COVID-19, a condition known as long COVID, U.S. researchers reported on  at ASCO 2022.

From a nationally representative sample of over 4.3 million people diagnosed with COVID-19 between January 2020 and February 2022, they identified 1,700 adults with long COVID and found that 37.3% were cancer patients. The most common cancers were skin (seen in 21.9% of the cancer patients), breast (17.7%), prostate (8.3%), lymphoma (8%) and leukemia (5.7%).

Among long COVID patients, those with cancer were older than non-cancer patients, more likely to have other medical conditions, and more likely to have been hospitalized for COVID-19. The researchers call for “further investigation to identify risk factors for long COVID in patients with cancer.”

Discover more from The Dispatch

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights